Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Journal: Nature Medicine

Published: 2020-07-10

DOI: 10.1038/s41591-020-0998-x

Affiliations: 13

Authors: 31

Go to article
Institutions Share
Vanderbilt Vaccine Center (VCC), VU, United States of America (USA) 0.38
John T. Milliken Department of Medicine, WUSTL, United States of America (USA) 0.12
Department of Medicine, Emory University, United States of America (USA) 0.10
Department of Molecular Microbiology, WUSTL, United States of America (USA) 0.07
Berkeley Lights, Inc., United States of America (USA) 0.06
UNC Department of Epidemiology, United States of America (USA) 0.06
Department of Pathology, Microbiology, and Immunology, VU, United States of America (USA) 0.04
Department of Medicine, U of T, Canada 0.03
Division of Allergy and Infectious Diseases, UW, United States of America (USA) 0.03
Harvard Division of Medical Sciences (DMS), United States of America (USA) 0.03
Department of Pediatrics, VU, United States of America (USA) 0.03
Department of Pathology and Immunology, WUSTL, United States of America (USA) 0.02
Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs (CHiiPs), WUSTL, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER